ISBC Financials 07/21/2014 21:52:20

Revolutionizing Access: Pharmaceuticals Meet Telehealth In an era where digital disruption is shaking every sector, Eli Lilly (NYSE:LLY) isn't sitting idle. They've just forged a partnership with Hims & Hers (NYSE:HIMS), one that's diving headfirst into the telehealth revolution. We're talking a slick merger of pharmaceuticals and digital platforms—offering FDA-approved...

Bridging Dental Care Gaps in New Mexico When the calendar flips to early November, Delta Dental of New Mexico is joining hands with the NM Mission of Mercy for a no-cost dental clinic at EXPO New Mexico. We're talking doors flying open at 5:15 a.m. sharp, on November 6 and 7. This isn’t some run-of-the-mill thing—they are targeting those who can't easily get or afford...

An Unexpected Shift in Sass's Seasonal Focus When you think November and December, it's easy to picture the hustle and bustle of holiday preparations—shopping, parties, running around. But toss all that hullabaloo out the window, because Sass Magazine has thrown a curveball for their 2026 release. They're steering the ship towards the calm, with their COZY Issue shaping...

Looks like Lululemon Athletica Inc. (NASDAQ: LULU) is in the hot seat, and not in the cozy yoga session kind of way. Investors are gearing up for a legal face-off thanks to a class action lawsuit alleging some serious corporate sleight of hand. What Triggered This Legal Storm? Turns out, between March 18 and September 3, 2026, things didn't go as planned for Lululemon....

What Tenax Investors Need to Know Alright, folks, time to pull up a chair and pay attention to what's brewing with Tenax Therapeutics—yeah, we're talking NASDAQ: TENX. The company's head is spinning as it's caught up in a securities class action lawsuit. What's the fuss? The fine print here accuses Tenax of misleading investors about the effectiveness of their product,...

A Landmark Moment in OLED Manufacturing Alright, let me drop a quick line here. TCL CSOT just shifted gears with their t8 production line in Guangzhou. It’s not your typical assembly line story—this one's all about pulling the future into the present. We're talking the world's first 8.6-generation Inkjet Printing OLED production line, for crying out loud. They've just...

The Corporate Chess Game at Datavault AI If there's one thing Wall Street hates, it's uncertainty. And boy, does Datavault AI (NASDAQ: DVLT) deliver plenty of it right now. Founder Nathaniel Bradley has lobbed a lawsuit at the board, claiming that Chairman and CFO Brett Moyer orchestrated a coup to oust him without proper board procedures. Talk about drama fit for a soap...

Investing in Koppers: A Mixed Bag in Q3 Well, it appears Koppers (NYSE: KOP) is doing a bit of a dance this quarter—some smooth steps, but a few stumbles in the rhythm when it comes to margins. The hardwood numbers tell an interesting tale, so let's break it down. Sales Edge Up, But Margins Suffer Koppers clocked in net sales of $499.1 million for the third quarter of...

Eyeing New Glaucoma Treatment Strategies You think glaucoma treatment is all about popping eye drops day in and day out? Well, turns out, things are shifting down in Racine, Wisconsin. Folks at HelloNation have been spilling the beans on earlier glaucoma interventions that might just lighten your load of daily medications. Doctors I. Paul Singh and R. Krishna Sanka...

When Revenue Goes South, Shares Follow Nothing like a Friday morning stock bloodbath to shake things up. MNTN, Inc. (NYSE:MNTN) had traders tossing back extra caffeine shots on November 5, 2026, when the company reported third-quarter revenues of $80.3 million. Let's just say that number didn't quite sit well with the folks who'd been banking on an $87.7 million...

Understanding the Class Action Lawsuit Against Perpetua Resources Corp. Investors in Perpetua Resources Corp. (NASDAQ: PPTA) should take note of recent developments regarding a class action securities lawsuit aimed at recovering losses incurred due to alleged securities fraud. This legal action encompasses claims made during a specific period, potentially affecting a...

Telix Pharmaceuticals Reports Record Revenues in Q3 2025 Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX) has unveiled an impressive financial performance for the third quarter of 2025, showcasing unaudited group revenues of approximately $206 million. This figure marks a substantial year-over-year increase of 53%, revealing the company's significant growth...

Bio-Techne's Commitment to Neuroscience Research Bio-Techne Corporation (NASDAQ: TECH) is preparing for an exciting presentation at the Society for Neuroscience's annual meeting, Neuroscience 2024. Scheduled for October 5-9 in Chicago, this prestigious event will feature Bio-Techne as they share advancements that are setting new standards in neuroscience research....

Class Action Suit Opportunities for Lineage, Inc. Investors The Rosen Law Firm, known for advocating investor rights, is calling attention to an essential opportunity for those who purchased common stock of Lineage, Inc. (NASDAQ: LINE). Investors should be aware of the impending lead plaintiff deadline of September 30, 2025. Why Join the Lawsuit? If you bought shares of...

AST SpaceMobile Gears Up for BlueBird 6 Launch AST SpaceMobile is set to launch its advanced satellite, BlueBird 6, marking a significant milestone for the company. This launch is crucial for boosting the firm’s space-based cellular broadband network and is being closely watched by investors eager to understand the company’s expansion into full-scale operations. Key...